+ Filter
Loading...
CD74 & CD22
Loading...Anti-CD74 & CD22 Products
- Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) (TAB-183-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fv - disulfide stabilized
- Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG1
- Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG4, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
- Human Anti-CD22 Recombinant Antibody (TAB-1722CL) (TAB-1722CL)
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1717CL) (TAB-1717CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Anti-Human CD22 Recombinant Antibody (RFB4) (TAB-1728CL)
-
- Application: IF, FC
- Human Anti-CD22 Recombinant Antibody (TAB-1718CL) (TAB-1718CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1719CL) (TAB-1719CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA
- Human Anti-CD22 Recombinant Antibody (TAB-1720CL) (TAB-1720CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA
- Human Anti-CD74 Recombinant Antibody (TAB-0569CL) (TAB-0569CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: IHC, WB
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1717CL-S(P)) (TAB-1717CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Anti-Human CD22 Recombinant Antibody (VM1000) (TAB-002LC)
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: FC, ELISA, SPR, FuncS
- Anti-Human CD22 Recombinant Antibody Fab Fragment (VM1000) (TAB-002LC-F(E))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: ELISA, SPR
- Human Anti-CD22 Recombinant Antibody (TAB-1729CL) (TAB-1729CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: IF, FC
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1715CL-F(E)) (TAB-1715CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1716CL-S(P)) (TAB-1716CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Anti-Human CD22 Recombinant Antibody scFv Fragment (VM1000) (TAB-002LC-S(P))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: ELISA, SPR
- Human Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-001LC-F(E)) (TAB-001LC-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric antibody (mouse/human)
- Application: ELISA
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1716CL-F(E)) (TAB-1716CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-001LC-S(P)) (TAB-001LC-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA
- Anti-Human CD22 Recombinant Antibody (hLL2) (TAB-0196CL)
-
- Application: Inhib, Cyt, FC, WB
- Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2) (TAB-0196CL-S(P))
-
- Application: ELISA, In vivo
- Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2) (TAB-0196CL-F(E))
-
- Application: ELISA, In vivo
- Anti-Human CD22 Recombinant Antibody (hLL2-Cys) (TAB-0197CL)
-
- Application: ELISA, In vivo
- Human Anti-CD22 Recombinant Antibody (TAB-1715CL) (TAB-1715CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1724CL) (TAB-1724CL)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG1, κ
- Application: Inhib
- Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2-Cys) (TAB-0197CL-S(P))
-
- Application: ELISA, In vivo
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1715CL-S(P)) (TAB-1715CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2-Cys) (TAB-0197CL-F(E))
-
- Application: ELISA, In vivo
- Human Anti-CD22 Recombinant Antibody (TAB-1716CL) (TAB-1716CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1725CL) (TAB-1725CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: Block, Cyt, ELISA, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-001LC) (TAB-001LC)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric antibody (mouse/human)
- Application: ELISA
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG1, κ
- Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: FC, IF, IHC, IP, FuncS
-
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: IF, FC
-
- Derivation: Human
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Human Anti-CD74 Recombinant Antibody (TAB-139CL) (TAB-139CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA
- Recombinant Anti-Human CD22 Antibody Fab Fragment (MOB-1248z-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab
- Application: IP, RIA, FuncS
- anti-CD22 immunotoxin RFB4 (scFv)-DT (AGTO-L048D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD22 immunotoxin RFB4 (IgG)-Gel (AGTO-G077G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD22 immunotoxin RFB4 (scFv)-RTA (AGTO-L048R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD22 immunotoxin RFB4 (IgG)-RTA (AGTO-G077R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Recombinant Anti-Human CD22 Antibody scFv Fragment (MOB-1248z-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: scFv
- Application: ELISA, WB, IF, FuncS
- anti-CD22 immunotoxin RFB4 (scFv)-Gel (AGTO-L048G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD22 immunotoxin RFB4 (IgG)-DT (AGTO-G077D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab' - G2a - kappa
- Application: ELISA, FC, IP, FuncS, IF, Neut, WB
- anti-CD22 immunotoxin RFB4 (scFv)-PE (AGTO-L048E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD22 immunotoxin RFB4 (IgG)-PE (AGTO-G077E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-1714CL-F(E)) (TAB-1714CL-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, WB
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1714CL-S(P)) (TAB-1714CL-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, WB
- Recombinant Anti-Human CD74 VHH Single Domain Antibody (NAB-466-VHH)
-
- Species Reactivity: Human
- Type: Llama VHH
- Application: FUNC, FA, IP, ChiP
- Mouse Anti-CD22 Recombinant Antibody (TAB-1714CL) (TAB-1714CL)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, WB
- anti-CD22 immunotoxin RFB4 (scFv)-Sap (AGTO-L048S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD22 immunotoxin RFB4 (IgG)-Sap (AGTO-G077S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-005LC-S(P)) (TAB-005LC-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC
- Anti-Human CD22 Recombinant Antibody Fab Fragment (TAB-004LC-F(E))
-
- Application: FC
- Mouse Anti-Human CD22 Recombinant Antibody scFv Fragment (TAB-003LC-S(P))
-
- Application: FC
- Anti-Human CD22 Recombinant Antibody scFv Fragment (TAB-004LC-S(P))
-
- Application: FC
- Mouse Anti-Human CD22 Recombinant Antibody Fab Fragment (TAB-003LC-F(E))
-
- Application: FC
- Anti-CD22 (clone 10F4)-SMCC-DM1 ADC (ADC-223CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-222CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone 10F4v3)-SPP-DM1 ADC (ADC-221CL)
-
- Target: CD22
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-220CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22-CL2E-SN-38 ADC (ADC-031LCT)
-
- Target: CD22
- Linker: CL2E
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-CD22 (clone 10F4v3)-mc-vc-PABC-MMAE ADC (ADC-195LZY)
-
- Target: CD22
- Linker: mc-VC-PABC(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
-
- Target: CD22
- Linker: acetyl butyrate linker
- Drug: calicheamicin
- Anti-CD22 (clone 7A2)-SMCC-DM1 ADC (ADC-215CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
-
- Targets: CD74 & CD22
- Type: BsFab
- Anti-CD74 (clone 006 (A))-mc-MMAF ADC (ADC-064CL)
-
- Target: CD74
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22-MC-MMAF ADC (ADC-032LCT)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (CR011)-vc-MMAE ADC (RG7593) (ADC-L028)
-
- Target: CD22
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone 10F4v1)-SMCC-DM1 ADC (ADC-216CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD74 (clone 005 (A))-mc-MMAF ADC (ADC-065CL)
-
- Target: CD74
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22-MCC-DM1 ADC (ADC-033LCT)
-
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v2)-SMCC-DM1 ADC (ADC-217CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD74 (clone 005 (A))-vc-MMAE ADC (ADC-062CL)
-
- Target: CD74
- Linker: VC (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22-AcBut-CalichDMH ADC (ADC-006LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-213CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (Pinatuzumab)-MC-VC-PABC-MMAE ADC (ADC-034LCT)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone 10F4v2)-MC-MMAF ADC (ADC-218CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (Inotuzumab)-hydrazone-Calicheamicin ADC (ADC-036LCT)
-
- Target: CD22
- Linker: hydrazone
- Drug: Calicheamicin
- Anti-CD22 (clone 10F4v3)-SMCC-DM1 ADC (ADC-219CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (Inotuzumab)-DIBO-doxorubicin ADC (ADC-037LCT)
-
- Target: CD22
- Linker: DIBO (dibenzylcyclooctynol)
- Drug: doxorubicin
- Anti-CD22 (clone hLL2)-SN-38 ADC (ADC-124CL)
-
- Target: CD22
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-CD22 (clone 10F4v3)-BMPEO-DM1 ADC (ADC-211CL)
-
- Target: CD22
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD74 (HuMax-CD74)-MC-vc-PAB-MMAF ADC (ADC-085LCT)
-
- Target: CD74
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (RFB4)-mcc-DM1 ADC (ADC-028LCT)
-
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD74 (clone 011 (B))-vc-MMAE ADC (ADC-060CL)
-
- Target: CD74
- Linker: VC (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone HB22.7)-saporin ADC (ADC-154LZY)
-
- Target: CD22
- Drug: saporin
- Anti-CD22-CL2A-SN-38 ADC (ADC-030LCT)
-
- Target: CD22
- Linker: CL2A
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-CD22-mc-vc-PABc-NMS249 ADC (ADC-097LZY)
-
- Target: CD22
- Linker: mc-VC-PABc (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: NMS249
- Anti-CD22 (clone 10F4v3)-MCC-DM1 ADC (ADC-194LZY)
-
- Target: CD22
- Linker: MCC(Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD74 (clone 011 (B))-mc-MMAF ADC (ADC-063CL)
-
- Target: CD74
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (clone hu10F4)-MCC-DM1 ADC (ADC-027LZY)
-
- Target: CD22
- Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD22 (clone 5E8)-SMCC-DM1 ADC (ADC-214CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD74 (clone 006 (A))-vc-MMAE ADC (ADC-061CL)
-
- Target: CD74
- Linker: VC (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone G5/44)-AcBut-CalichDMH ADC (ADC-003LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
- Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-212CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (10F4)-AcBut-Calicheamicin ADC (ADC-029LCT)
-
- Target: CD22
- Linker: AcBut
- Drug: Calicheamicin
- Anti-CD22-mc-vc-PABc-MMAE ADC (ADC-033LZY)
-
- Target: CD22
- Linker: mc-VC-PABc(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
CD74 (CD74 Molecule) is a Protein Coding gene. Diseases associated with CD74 include Undifferentiated Pleomorphic Sarcoma and Mantle Cell Lymphoma. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and Innate Immune System. Gene Ontology (GO) annotations related to this gene include identical protein binding and amyloid-beta binding.
CD22 or cluster of differentiation-22, is a molecule belonging to the SIGLEC family of lectins. It is found on the surface of mature B cells and to a lesser extent on some immature B cells. Generally speaking, CD22 is a regulatory molecule that prevents the overactivation of the immune system and the development of autoimmune diseases. CD22 is a sugar binding transmembrane protein, which specifically binds sialic acid with an immunoglobulin (Ig) domain located at its N-terminus. The presence of Ig domains makes CD22 a member of the immunoglobulin superfamily. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signalling.

